Ad is loading...
CURE vs SPXL
CURE vs SPXL Comparison Chart
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
CURE vs. SPXL commentary
Apr 28, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURE is a StrongBuy and SPXL is a Buy.
SUMMARIES
FUNDAMENTALS
Fundamentals
SPXL has more net assets: 3.97B vs. CURE (127M). CURE has a higher annual dividend yield than SPXL: CURE (-5.194) vs SPXL (-25.295). CURE was incepted earlier than SPXL: CURE (14 years) vs SPXL (16 years). SPXL (0.91) has a lower expense ratio than CURE (0.96). SPXL has a higher turnover CURE (23.00) vs CURE (23.00).
| CURE | SPXL | CURE / SPXL | |
| Gain YTD | -5.194 | -25.295 | 21% |
| Net Assets | 127M | 3.97B | 3% |
| Total Expense Ratio | 0.96 | 0.91 | 105% |
| Turnover | 23.00 | 29.00 | 79% |
| Yield | 1.00 | 0.96 | 105% |
| Fund Existence | 14 years | 16 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| CURE | SPXL | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 90% | 4 days ago 90% |
| Stochastic ODDS (%) | 4 days ago 88% | 4 days ago 87% |
| Momentum ODDS (%) | 4 days ago 83% | 4 days ago 90% |
| MACD ODDS (%) | 4 days ago 88% | 4 days ago 90% |
| TrendWeek ODDS (%) | 4 days ago 90% | 4 days ago 90% |
| TrendMonth ODDS (%) | 4 days ago 90% | 4 days ago 90% |
| Advances ODDS (%) | 4 days ago 90% | 4 days ago 90% |
| Declines ODDS (%) | 8 days ago 90% | 13 days ago 89% |
| BollingerBands ODDS (%) | 4 days ago 89% | 4 days ago 90% |
| Aroon ODDS (%) | 4 days ago 90% | 4 days ago 87% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Show more...
Show more...